WallStreetZenWallStreetZen

NYSE: NMR
Nomura Holdings Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their NMR stock forecasts and price targets.

Forecast return on equity

Is NMR forecast to generate an efficient return?
Company
8.12%
Industry
18.86%
Market
33.96%
NMR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NMR forecast to generate an efficient return on assets?
Company
0.49%
Industry
3.32%
NMR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NMR earnings growth forecast

How is NMR forecast to perform vs Capital Markets companies and vs the US market?
Company
66.67%
Industry
42.45%
Market
36.52%
NMR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NMR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NMR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NMR revenue growth forecast

How is NMR forecast to perform vs Capital Markets companies and vs the US market?
Company
5.15%
Industry
7.94%
Market
15.32%
NMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NMR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NMR vs Capital Market Stocks

TickerPricePrice TargetUp/downsideConsensus
NMR$6.31N/AN/A
LPLA$239.63$300.57+25.43%Buy
HOOD$24.63$21.25-13.72%Hold
RJF$113.51$128.88+13.54%Hold
IBKR$123.66$142.00+14.83%Strong Buy

Nomura Holdings Stock Forecast FAQ

What is NMR's forecast return on equity (ROE) for 2025-2025?

(NYSE: NMR) forecast ROE is 8.12%, which is considered weak.

If you're new to stock investing, here's how to buy Nomura Holdings stock.

What is NMR's forecast return on assets (ROA) for 2025-2025?

(NYSE: NMR) forecast ROA is 0.49%, which is lower than the forecast US Capital Markets industry average of 3.32%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.